Search Results

You searched for : LatestPharmaNewsDec2  

LYNPARZA (olaparib) Receives Three New Approvals in Japan

LYNPARZA has been approved in Japan for the treatment of three types of advanced cancer: ovarian, prostate and pancreatic cancer....
Dec 28

Lupin launches Meloxicam Capsules

Meloxicam Capsules is the generic equivalent of Vivlodex Capsules of Zyla Life Sciences US, Inc., and indicated for the management of osteoarthritis (OA) pain....
Dec 28

European Medicines Agency Validates Bristol Myers Squibb’s Application for Zeposia (ozanimod) for the Treatment of Ulcerative Colitis

If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis....
Dec 28

PFIZER AND BIONTECH TO SUPPLY THE U.S. WITH 100 MILLION ADDITIONAL DOSES OF COVID-19 VACCINE

...
Dec 24

Bristol Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed Methylated Glioblastoma Multiforme

...
Dec 23

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris Nasal Spray

...
Dec 23

Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of COVID-19

...
Dec 23

Dr. Reddy's, Global Response Aid, and Appili Therapeutics announce the filing of an application for REEQONUS Tablets

...
Dec 22

Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma

Tezepelumab’s effect on other efficacy parameters was similar to those observed in previous trials, including the registrational Phase III NAVIGATOR trial....
Dec 22

Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%...
Dec 21

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

This authorization represents the first time people living with HIV in Europe may be able to receive a long-acting injectable treatment that removes the ...
Dec 21

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules

Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules...
Dec 21

Aprea Therapeutics receives FDA Fast Track Designation for Eprenetapopt in the treatment of Acute Myeloid Leukemia (AML)

Eprenetapopt indicated for the treatment of TP53 Mutant Acute Myeloid Leukemia (AML)...
Dec 02

MacroGenics and EVERSANA joins hand to support launch and commercialization of Margetuximab

Companies to commercialize margetuximab in the United States, if approved....
Dec 02

Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India

This will be a multicenter and randomized controlled study, which will include a safety and immunogenicity study....
Dec 02

PFIZER AND BIONTECH ACHIEVE FIRST AUTHORIZATION IN THE WORLD FOR A VACCINE TO COMBAT COVID-19

...
Dec 02

LuminUltra expands with acquisition of Source Molecular Corporation

LuminUltra increases testing capacity including the range of COVID-19 offerings with the acquisition ...
Dec 02

17 Matching result(s) found!

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026